Search Orphan Drug Designations and Approvals
-
| Generic Name: | Small molecule Ewing Sarcoma breakpoint region 1/Friend leukemia virus integration 1 fusion protein inhibitor |
|---|---|
| Date Designated: | 06/30/2016 |
| Orphan Designation: | Treatment of Ewing sarcoma |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Georgetown University 2115 Wisconsin Avenue NW, Suite G202 Washington, District of Columbia 20007 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







